Cargando…
Involvement of PI3K Pathway in Glioma Cell Resistance to Temozolomide Treatment
The aim of the study was to investigate the anticancer potential of LY294002 (PI3K inhibitor) and temozolomide using glioblastoma multiforme (T98G) and anaplastic astrocytoma (MOGGCCM) cells. Apoptosis, autophagy, necrosis, and granules in the cytoplasm were identified microscopically (fluorescence...
Autores principales: | Zając, Adrian, Sumorek-Wiadro, Joanna, Langner, Ewa, Wertel, Iwona, Maciejczyk, Aleksandra, Pawlikowska-Pawlęga, Bożena, Pawelec, Jarosław, Wasiak, Magdalena, Hułas-Stasiak, Monika, Bądziul, Dorota, Rzeski, Wojciech, Reichert, Michał, Jakubowicz-Gil, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152763/ https://www.ncbi.nlm.nih.gov/pubmed/34068110 http://dx.doi.org/10.3390/ijms22105155 |
Ejemplares similares
-
Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment
por: Jakubowicz-Gil, Joanna, et al.
Publicado: (2013) -
Lensoside Aβ as an Adjuvant to the Anti-Glioma Potential of Sorafenib
por: Maciejczyk, Aleksandra, et al.
Publicado: (2021) -
LY294002 and sorafenib as inhibitors of intracellular survival pathways in the elimination of human glioma cells by programmed cell death
por: A, Zając, et al.
Publicado: (2021) -
Quercetin and Sorafenib as a Novel and Effective Couple in Programmed Cell Death Induction in Human Gliomas
por: Jakubowicz-Gil, Joanna, et al.
Publicado: (2013) -
Antiglioma Potential of Coumarins Combined with Sorafenib
por: Sumorek-Wiadro, Joanna, et al.
Publicado: (2020)